GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as LongBusiness Wire • Wednesday
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor TypesBusiness Wire • 09/13/24
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in ItalyBusiness Wire • 09/10/24
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/27/24
Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer ScreeningBusiness Wire • 08/22/24
Guardant Health (GH) Recently Broke Out Above the 20-Day Moving AverageZacks Investment Research • 08/08/24
Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/08/24
Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceBusiness Wire • 08/07/24
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal CancerBusiness Wire • 08/07/24
What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 EarningsZacks Investment Research • 08/06/24
Guardant Health's FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal CancerBusiness Wire • 08/01/24
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence StrategiesBusiness Wire • 08/01/24
Guardant Health's stock up after FDA approves its blood test for colon-cancer screeningMarket Watch • 07/30/24
Guardant Health's Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer ScreeningBusiness Wire • 07/29/24
Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024Business Wire • 07/24/24